A system dynamics model of Australian opioid pharmacotherapy maintenance treatment Jenny Chalmers*, Alison Ritter*, Mark Heffernan** and Geoff McDonnell***

Slides:



Advertisements
Similar presentations
THE COMMONWEALTH FUND 1 Bending the Curve: Options for Achieving Savings and Improving Value in Health Spending Cathy Schoen Senior Vice President The.
Advertisements

Evaluating health informatics projects Reasons for and problems of evaluation Objective model Subjective model.
Gautam Sanka. Analyze and Elucidate the behavior of complex systems Complex Systems Collection of interconnected elements (system) Behavior and Characteristics.
Funding primary care providers – the how, why and what for. Richard De Abreu Lourenço CHERE, UTS.
Modelling and planning care services for long-term conditions Southern Institute for Health Informatics 2006 Conference 22nd September 2006 Steffen Bayer.
Slide 5.1 Topic 5. Supporting programs aimed at reducing the spread of HIV among and from IDU Needle and Syringe Programs Opioid Substitution Treatment.
COMP8130 and COMP4130 Adrian Marshall Verification and Validation Risk Management Adrian Marshall.
Substance use, women and parenting: preliminary results from a NSW study with women in substance use treatment Stephanie TAPLIN, Richard Mattick & Melissa.
Australia’s Healthcare System
MOSES: Modelling and Simulation for e-Social Science Mark Birkin, Martin Clarke, Phil Rees School of Geography, University of Leeds Haibo Chen, Institute.
Renewable Energy Policy: A Local Government Perspective Alison Johnson for PEC624: Dissertation.
1 Webinar: Challenges in Clinical Training Ben Wallace, Executive Director, Clinical Training Reform Health Workforce Australia.
A meta-synthesis of clinicians’ experiences and perceptions of benzodiazepine prescribing: implications for the integration of health services Coral Sirdifield,
Paul Griffiths and Roland Simon Wrap-up presentation What has the EMCDDA learned ?
1 of 27 How to invest in Information for Development An Introduction Introduction This question is the focus of our examination of the information management.
Availability of children’s medicines in Africa, 2007 Jane Robertson, Gilles Forte, Suzanne Hill.
Trends in Opioid Use and Overdose in BC: Making the case for greater availability of Take Home Naloxone programs Ashraf Amlani Harm Reduction Epidemiologist.
Health Systems and EU enlargement - an accession country’s view Tit Albreht, M.D., M.Sc., Institute of Public Health of the Republic of Slovenia Bad Gastein,
Standard 1- Leadership & Vision Sara Saffell Amy Blackwell Marilyn McDonald 1. Leadership and Vision-Educational leaders inspire a shared vision for comprehensive.
Horizon Scanning: future skills and competences of the health workforce in Europe MATT EDWARDS and JOHN FELLOWS WP6, EU JA on Health Workforce Planning.
Capital Insight Pty Limited ABN Berry Street North Sydney NSW 2060 t f Health Economics.
This report is solely for the use of the client organisation. This material was used by HVR Consulting Services Ltd during a presentation and does not.
Health Care in Australia Medicare and Private Health Insurance.
G IOVANNA G IUFFRE ’, ISIS - S CENARIO BUILDING AND OUTLOOK OF THE PROJECT FRESHER WORKSHOP LISBON, 26 O CTOBER 2015.
Barriers & benefits: transfer of opioid- dependent people on methadone maintenance treatment from secondary to primary health care NAPCRG Tucson 2006 Felicity.
Investment Funds, Markets Liquidity and the Investor Financial Risks International Forum Paris Europlace Institute of Finance 21 March 2016 David Lawton,
G1 (BAII Plus) HEALTH INSURANCE Insurance against the risk of incurring medical expenses among individuals. Insurancemedical expenses What can health.
Introduction and Overview
International perspectives on drug treatment policy
Risk-based Global Insurance Capital Standard Version 1
What’s at stake for California under proposals to unwind federal health reform March 10, 2017 Shannon McConville.
Australia’s Approach to Regulatory Reform
What makes a difference
Background Significant reform across aged care sector aiming to create greater national consistency and more integration across the care system. Changes.
Complex Adaptive Systems (CAS)
3 July 2017 Working with students with Personality Disorder and Risk: Developing the Student Health Emotion Regulation Pathway (SHERPA) Dr Ian Barkataki.
Capital Project / Infrastructure Renewal – Making the Business Case
About Operational Research
System Dynamics Dr Jennifer Morgan.
Opioids Aware A resource for patients and HCPs to support prescribing of opioid medicines for pain Sue Mulvenna CDAO NHSE S SW March 2016.
Change in malaria treatment policy: A study of its immediate effects on hospital malaria drug management, utilization of hospital facilities and prescription.
Person Centred Care in NHS Wales
A Level Playing Field? Exploring Partnership Working Between the NHS and Voluntary Hospices in Wales.
Creating a whole-school coaching culture
Dyslexia and Impacts National Forum on Guidance, 18th October 2017
Alison Ritter, Jenny Chalmers, Lynda Berends
Simulation - Introduction
Harmoko, MD#, Edward, MD #Institut Kesehatan Helvetia
Introduction and Overview
Matters arising- 29th March
Connecting people with food policy
Methadone Scenario 3 Based on Stigma & Trust Findings from the
Opioids in Butte County
Systematic Review of Untreated Remission from Alcohol Problems: Estimation Lies in the Eye of the Beholder Richard Mellor1, Kari Lancaster2, Alison Ritter3.
Aged care research project overview of findings and key themes
Impacts of the new child care subsidy ON APPROVED PROVIDERS
Workshop 3 – Social and Governance November 2006
2018 Postgraduate Research Symposium
Untreated Remission from Alcohol Problems: A Mixed Methods Approach
Managerial and Regulatory Strategies to Improve Drug Use
IOPS TOOLKIT RISK-BASED SUPERIVSION
Standard Treatments.
What existing research and data can tell us
Pharmacy – Fully Insured versus Self Funding
ECONOMICS IN THE WFD PROCESS
A PILOT STUDY EXAMINING CRITERIA USED TO SELECT DRUGS FOR HOSPITAL, PROVINCIAL AND NATIONAL FORMULARIES Robertson J, Newby DA, Pillay T, Walkom EJ The.
SIMULATION IN THE FINANCE INDUSTRY BY HARESH JANI
Informing local suicide prevention through co-design of a system dynamics model in Greater Western Sydney (Australia) With a small research partnership.
A LONGITUDINAL POLICY ANALYSIS OF THE IMPACT ON PRESCRIBING PATTERNS AND MEDICATION COST OF A GENERIC DISPENSING POLICY IN A TEACHING HOSPITAL IN THAILAND.
The importance of collaboration in regulatory stewardship
Presentation transcript:

A system dynamics model of Australian opioid pharmacotherapy maintenance treatment Jenny Chalmers*, Alison Ritter*, Mark Heffernan** and Geoff McDonnell*** * National Drug and Alcohol Research Centre, UNSW; ** Evans & Peck Pty Ltd; *** Adaptive Care Systems Pty Ltd.

Introduction Motivation- Is there potential for pharmacotherapy programs to better meet demand in relation to availability, accessibility and affordability of treatment Aim of research - develop a system dynamics model as a tool for policy makers to illustrate how treatment system as a whole responds to possible policy reforms Research questions - explore 3 areas of concern 80% of patients pay dispensing fees of $5/day. What would it cost the Government to cover them? Can system cope with increased demand for treatment? What would happen if supply of treatment places fell?

Why use this approach? Why a modeling approach? Why system dynamics? Difficult to explore the impacts of policy changes in real world. Simulation models are a safe, risk-free environment for experimenting with future policy options and gaining consensus among stakeholders. Why system dynamics? Rather than focus on the complex behaviour patterns of individuals, system dynamics elicits the structures, policies and “local” informal rules of the system from a range of qualitative and quantitative sources. Pattern-oriented approach to model development and calibration with pooled data. System dynamics 101 A computable representation of stocks (accumulations), flows (rates) and information feedbacks that drive overall behaviour over time.

Background Australia’s pharmacotherapy system is over 20 years old Close to 40,000 in treatment 70% treated with methadone Treatment system managed by state governments and funded by Commonwealth and state governments plus patient

The model

Model assumptions Model is Australia-wide Daily dispensing Each episode of treatment identical Each between treatment episode identical

Systems of care

Issue 1: Monthly methadone dispensing costs borne by Government

Issue 2: Demand increase: treatment novices vs treatment experienced

Issue 3: Impact on methadone patient numbers of limited entry to prescribers

Conclusion The model has the potential to serve as a spring-board for debates about policy directions In this paper we: Demonstrate that source of increased demand matters; Simulate the financial implications for Government of subsidising dispensing of methadone; and explore the implications of limiting entry of treatment seekers to prescribers.